EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Targeting LTBP2 Reveals a Novel Anti-Cardiac Remodeling Mechanism of Finerenone Against Doxorubicin-Induced Cardiotoxicity

Heng Zhang iD, Nan Zhao, Saiyang Xie, Lanlan Li, Xiaofeng Zeng, Shasha Wang, Ling Yan, Bo Shen iD, Wei Deng

Biomolecules · 05.12.2025 · 15 (12) · 1703

DOI: 10.3390/biom15121703 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biomolecules, online erschienen am 05.12.2025. Verfasst von Heng Zhang und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Renmin Hospital of Wuhan University, Wuhan 430060, China. Hauptthemen laut MEDLINE: Doxorubicin, Cardiotoxicity, Latent TGF-beta Binding Proteins, Naphthyridines. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Research & Development plan of Hubei Province, Research and Development Program of Hubei Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Despite the clinical efficacy of doxorubicin (DOX), effective strategies to prevent its cardiotoxicity are still lacking. Finerenone, a nonsteroidal mineralocorticoid receptor antagonist (MRA), has demonstrated cardioprotective properties; however, its role and mechanism in DOX-induced cardiotoxicity (DIC) remain unclear. In this study, Finerenone treatment was found to significantly alleviate DOX-induced cardiac dysfunction and pathological remodeling in both mouse models and cultured cells. Mechanistically, molecular docking suggests that Finerenone may directly bind to Latent Transforming Growth Factor Beta Binding Protein 2 (LTBP2), a key regulator of TGF-β bioavailability. This potential binding could inhibit the LTBP2–TGF-β axis, thereby suppressing DOX-induced activation and subsequent Smad3 phosphorylation. The importance of this pathway was supported by the similar anti-fibrotic effects observed with the TGF-β inhibitor LY2109761. However, our findings on the direct binding of Finerenone to LTBP2 are preliminary and require further validation through additional experimental approaches. These results identify LTBP2 as a novel direct target of Finerenone and reveal an additional mechanism underlying its cardioprotective action, suggesting its potential repurposing for the prevention of DIC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DoxorubicinCardiotoxicityLatent TGF-beta Binding ProteinsNaphthyridinesVentricular RemodelingAnimalsMiceMolecular Docking SimulationMaleHumansTransforming Growth Factor betaMice, Inbred C57BLSmad3 ProteinMyocytes, Cardiac

Stichwörter der Autor:innen

FinerenoneLTBP2cardiac remodelingcardiotoxicitydoxorubicin

Substanzen

DoxorubicinfinerenoneLatent TGF-beta Binding ProteinsNaphthyridinesTransforming Growth Factor betaSmad3 Protein

Autor:innen und Institutionen

  • Department of Cardiology, Renmin Hospital of Wuhan University, Wuhan 430060, China.
  • Hubei Key Laboratory of Metabolic and Chronic Diseases, Wuhan 430060, China.
  • Cardiovascular Research Institute, Wuhan University, Wuhan 430060, China.

ORCID-Profile: Heng Zhang, Bo Shen

Förderung

  • National Natural Science Foundation of China
  • Research & Development plan of Hubei Province
  • Research and Development Program of Hubei Province

Zitieren

APA

Zhang, H., Zhao, N., Xie, S., Li, L., Zeng, X., Wang, S., Yan, L., Shen, B., & Deng, W. (2025). Targeting LTBP2 Reveals a Novel Anti-Cardiac Remodeling Mechanism of Finerenone Against Doxorubicin-Induced Cardiotoxicity. Biomolecules, 15(12), 1703. https://doi.org/10.3390/biom15121703

Vancouver

Zhang H, Zhao N, Xie S, Li L, Zeng X, Wang S, et al. Targeting LTBP2 Reveals a Novel Anti-Cardiac Remodeling Mechanism of Finerenone Against Doxorubicin-Induced Cardiotoxicity. Biomolecules. 2025;15(12):1703. doi:10.3390/biom15121703

BibTeX
@article{Zhang2025,
  author = {Zhang, Heng and Zhao, Nan and Xie, Saiyang and Li, Lanlan and Zeng, Xiaofeng and Wang, Shasha and Yan, Ling and Shen, Bo and Deng, Wei},
  title = {Targeting LTBP2 Reveals a Novel Anti-Cardiac Remodeling Mechanism of Finerenone Against Doxorubicin-Induced Cardiotoxicity},
  journal = {Biomolecules},
  year = {2025},
  volume = {15},
  number = {12},
  pages = {1703},
  doi = {10.3390/biom15121703}
}
Kostenlos starten →